Sponsors V2
Thank you to all of our sponsors.If you are interested in becoming a sponsor, please contact Dylan Ashley. Partners Presidential Sponsors Executive Sponsors General Sponsors Corporate Benefactors Emerging Companies
Thank you to all of our sponsors.If you are interested in becoming a sponsor, please contact Dylan Ashley. Partners Presidential Sponsors Executive Sponsors General Sponsors Corporate Benefactors Emerging Companies
Thank you to all of our sponsors.If you are interested in becoming a sponsor, please contact Dylan Ashley. Partners Presidential Sponsors Executive Sponsors General Sponsors Emerging Companies Corporate Benefactors
As a reminder, the U.S. House of Representatives Committee on Oversight and Reform previously found, in a 2021 report, that PBM-negotiated rebates are not correlated with the list prices set by drug companies. The report also finds that “drug companies have
In case you missed it, JC Scott, president and CEO of the Pharmaceutical Care Management Association (PCMA), wrote an op-ed in D.C. Journal calling on drug companies to lower their egregious prices for GLP-1 drugs for weight loss. Scott highlights
In case you missed it, the growing consensus surrounding the recent actions from the Federal Trade Commission (FTC), including releasing an interim staff report on pharmacy benefit managers (PBMs) without substantial data to back up the wide sweeping claims and
©2024 PCMA. All Rights Reserved.